{"database": "lobbying", "table": "lobbying_activities", "rows": [[2859682, "e16f02e0-f030-4c2f-9ff0-287d3c7ba8b9", "Q3", "AUBURN HEALTH STRATEGIES, LLC", 292697, "AOAC INTERNATIONAL", 2022, "third_quarter", "FOO", "Methods of analysis regulation", "Food & Drug Administration (FDA)", 10000, null, 0, 0, "2022-10-01T14:17:01-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2859682"], "units": {}, "query_ms": 1.6648389864712954, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}